Britain’s largest union, Unite today (Monday 19 May) urged AstraZeneca’s shareholders to avoid the temptation to make a ‘quick buck’ and to back the board and the workforce, following the latest bid from Pfizer.
Warning that a takeover by Pfizer would destabilise AstraZeneca, potentially leading to job losses and the loss of vital research and development, the union called on shareholders to stand firm and back AstraZeneca’s long term strategy.
The call follows AstraZeneca’s rejection of a final £69 billion takeover offer from Pfizer, who said the deal would bring “uncertainty and risk.”
Commenting, Unite assistant general secretary Tony Burke, said: “AstraZeneca’s shareholders should avoid the temptation to make a quick buck. The company has a long term plan and we would urge shareholders to back the workforce and the board.
“The latest offer from Pfizer still raises more questions than it answers. It would not only destabilise AstraZenca, but undermine the UK’s science and research base and put a jewel in the Britain’s manufacturing crown at risk.
“Shareholders should stand firm and look to the long term.”
For further information please contact Unite head of media and campaigns Alex Flynn on 020 3371 2066 or 07967 665869.
Twitter: @unitetheunion Facebook: unitetheunion1
Notes to editors
• Unite is Britain and Ireland’s largest trade union with over 1.4 million members working across all sectors of the economy. The general secretary is Len McCluskey.